Nvidia Unveils AI Microservices for Healthcare Innovation at GTC Conference
At its annual GTC conference, Nvidia introduced 25 generative AI microservices aimed at revolutionizing the healthcare [...]
Texas Medical Board Proposes Guidance on Legal Abortion in Medical Emergencies
The Texas Medical Board has released draft guidance aimed at clarifying when abortions are legally permissible [...]
Job Cuts at Bellus Health Following GSK’s $2 Billion Acquisition
In the wake of GSK's $2 billion acquisition of Bellus Health, an undisclosed number of Bellus [...]
Expanded Coverage for Anti-Obesity Drugs in U.S. Government Health Programs
The Centers for Medicare and Medicaid Services (CMS) has issued guidance for Medicare Part D plans [...]
U.S. Drug Overdose Deaths Hit Record High in 2022, Showing Signs of Stabilizing Crisis
The U.S. saw a record 107,941 drug overdose deaths in 2022, a slight rise from the [...]
The Evolution and Future of CAR-T Cell Therapies: Overcoming Manufacturing Hurdles for Cancer Treatment
In the summer of 2017, Novartis took a significant step in cancer treatment with the approval [...]
EPA’s Asbestos Ban: A Major Step Forward with Long-Term Public Health Implications
The Environmental Protection Agency (EPA) has announced a comprehensive ban on all forms of asbestos in [...]
AstraZeneca Acquires Fusion Pharmaceuticals for $2 Billion
AstraZeneca has announced a $2 billion acquisition of Fusion Pharmaceuticals, significantly investing in the burgeoning field [...]
UnitedHealth Advances $2 Billion to Providers After Cyberattack on Change Healthcare
UnitedHealth Group has distributed over $2 billion in advance payments to healthcare providers impacted by a [...]
EU Spearheads Real-World Evidence Projects to Revolutionize Healthcare Decision-Making
The European Union is in charge of integrating real-world evidence (RWE) and advanced data analytics into [...]
Zephyr AI Secures $111M in Series A Funding to Revolutionize Healthcare with AI
Zephyr AI, a US-based healthcare technology company, has successfully raised $111 million in a Series A [...]
FDA Outlines Regulatory Framework for AI in Medical Products
The FDA has published a comprehensive plan to regulate artificial intelligence (AI) in medical products, marking [...]
The Experimental Quest for Longevity: Rapamycin’s Rising Popularity
At 77, David Sandler from Bergen County, N.J., has ventured into an experimental approach to longevity [...]
AstraZeneca Boosts Rare Diseases Portfolio with Acquisition of Amolyt Pharma
AstraZeneca has announced a definitive plan on Thursday, March 14 to acquire Amolyt Pharma, a clinical-stage [...]
FDA Approves First Drug for Fatty Liver Disease by Madrigal Pharmaceuticals
The FDA has approved Madrigal Pharmaceuticals' Rezdiffra, the first treatment for metabolic dysfunction-associated steatohepatitis (MASH), offering [...]
President Biden’s State of the Union: A Focus on Healthcare, Drug Pricing, and Reproductive Rights Amid Election Season
In his State of the Union address, President Joe Biden highlighted healthcare as a central priority, [...]
Biden Administration Proposes Increased FDA Funding for FY 2025 to Enhance Innovation and Health Services
Just days after the FDA’s fiscal year 2024 appropriations package was passed, the Biden administration is [...]
FDA Delays Approval of Eli Lilly’s Alzheimer’s Drug Donanemab, Citing Safety and Efficacy Concerns
Eli Lilly's Alzheimer's drug donanemab faces delays in FDA approval due to concerns over safety and [...]
Beyfortus: A New Milestone in RSV Prevention for Young Children
Beyfortus, a newly developed monoclonal antibody product by AstraZeneca and Sanofi, has shown a remarkable 90% [...]
GLP-1 RA Use Linked to Increased Residual Gastric Content in Fasted Patients
A cross-sectional study involving 124 fasted patients undergoing elective procedures under anesthesia revealed that users of [...]
Boundless Bio Eyes Nasdaq with Innovative Cancer Treatment Approach
Boundless Bio, a San Diego-based biotech startup, has announced its intention to go public on the [...]
The Stigma and Systemic Barriers Against Lifesaving Opioid Addiction Treatments in the U.S.
The opioid overdose epidemic has been devastating the U.S. for nearly three decades despite the availability [...]
Biden Administration Progresses on Lowering Drug Prices Amid Legal and Political Challenges
The Biden Administration announced continued progress in its campaign to reduce drug prices, highlighting that all [...]
Breakthrough in Fetal Disease Study: Viable Cells in Amniotic Fluid Offer New Research Avenues
Researchers in the U.K. have made a significant discovery in fetal health research by identifying viable [...]
Major US Pharmacy Chains to Offer Abortion Pill Mifepristone
CVS and Walgreens, the two largest pharmacy chains in the United States, announced plans to dispense [...]